Newsmeme!
Discover News you didn't know existed
Thromboembolism
News
Related Video News
No related video news stories found.
Related Videos
No related videos found.
Inverness Medical Launches Portable Blood Testing Monitor To Warn Patients And Their Physicians Of Potential Blood Clots
Published September 6, 2008, 7:14 am, Medical News Today
Inverness Medical Physician Diagnostics Group, a division of Inverness Medical Innovations, announced the launch of the INRatio®2 PT/INR Monitoring System, a portable device that measures blood-clotting time, also known as prothrombin time, using one drop of blood from a patient's finger.
Inverness Medical Launches Portable Blood Testing Monitor to Warn Patients and Their Physicians of Potential Blood Clots
Published September 5, 2008, 2:52 am, Centre Daily Times
Inverness Medical Physician Diagnostics Group, a division of Inverness Medical Innovations, today announced the launch of the INRatio(R)2 PT/INR Monitoring System, a portable device that measures blood-clotting time, also known as prothrombin time, using one drop of blood from a patient's finger. The INRatio2 is used by healthcare professionals and their patients in the management of warfarin, a ...
Inverness Medical Launches Portable Blood Testing Monitor to Warn Patients and Their Physicians of Potential Blood Clots
Published September 5, 2008, 2:00 am, Business Wire via Yahoo! Finance
SAN JOSE, Calif.----Inverness Medical Physician Diagnostics Group, a division of Inverness Medical Innovations, today announced the launch of the INRatio®2 PT/INR Monitoring System, a portable device that measures blood-clotting time, also known as prothrombin time, using one drop of blood from a patient's finger.
'HealthGate Governance(TM)' Application Addresses Mounting Requirements for Governance, Transparency and ...
Published September 4, 2008, 6:39 am, Centre Daily Times
HealthGate Data Corp. announced today the availability of HealthGate Governance(TM), a collection of web-based tools designed specifically to help hospitals and health systems manage the complex governance issues associated with quality and care improvement initiatives. HealthGate Governance is based on HealthGate's healthcare industry-specific collaboration, document lifecycle management and ...
'HealthGate Governance(TM)' Application Addresses Mounting Requirements for Governance, Transparency and ...
Published September 4, 2008, 6:10 am, Business Wire via Yahoo! Finance
BURLINGTON, Mass.----HealthGate Data Corp. announced today the availability of HealthGate Governance™, a collection of web-based tools designed specifically to help hospitals and health systems manage the complex governance issues associated with quality and care improvement initiatives.
Secondary Prevention In Acute Coronary Syndrome - Rivaroxaban Phase II Data In ACS To Be Presented At AHA Congress In ...
Published September 4, 2008, 4:11 am, Medical News Today
The development of Xarelto® (rivaroxaban), a novel oral anticoagulant, has taken another step forward. Phase II results in patients with acute coronary syndrome (ACS) have been chosen for the Late Breaking Clinical Trial session at the American Heart Association's (AHA) upcoming Annual Meeting in New Orleans, USA. The presentation will be held on November 10th, 2008 by C. Michael Gibson, M.D.
AsiaNet Daily Summary - Press Releases for Wednesday, Sept 3, 2008
Published September 3, 2008, 3:17 am, Thaipr.net
HK SEMINAR... CHICAGO and FRANKFURT: RTS Realtime Systems Group will present a seminar on algorithmic trading trends, news and opportunities [in conjunction with the Electronic Trading Asi
Daiichi Sankyo Announces Clinical Study Data for Oral Factor Xa Inhibitor DU-176b
Published September 2, 2008, 12:17 am, Thaipr.net
Data presented today at the Annual Congress of the European Society of Cardiology showed that the investigational oral Factor Xa inhibitor DU-176b reduced the incidence of venous thromboembolism (VTE)
Daiichi Sankyo Announces Clinical Study Data for Oral Factor Xa Inhibitor DU-176b
Published September 1, 2008, 11:31 pm, PR Newswire via Yahoo! Finance
Data presented today at the Annual Congress of the European Society of Cardiology showed that the investigational oral Factor Xa inhibitor DU-176b reduced the incidence of venous thromboembolism compared with dalteparin among patients undergoing elective unilateral hip replacement surgery.
My Pharmiweb.com
Published September 1, 2008, 2:24 am, PharmiWeb
London, 29 July 2008 – Boehringer Ingelheim today welcomed the National Institute for Health and Clinical Excellence (NICE)’s Final Appraisal Determination (FAD) which gives a draft recommendation that Pradaxa® (dabigatran etexilate), within its marketing authorisation, is recommended as an option for the primary prevention of venous thromboembolic events in adults who have undergone elective ...
Related News Resources:
> HGH News
News Directory
Get started fast by using a pre-defined news directory category
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |